308 related articles for article (PubMed ID: 28560678)
21. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
Kasimir-Bauer S; Hoffmann O; Wallwiener D; Kimmig R; Fehm T
Breast Cancer Res; 2012 Jan; 14(1):R15. PubMed ID: 22264265
[TBL] [Abstract][Full Text] [Related]
22. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
24. EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
Perelmuter VM; Grigoryeva ES; Savelieva OE; Alifanov VV; Andruhova ES; Zavyalova MV; Bragina OD; Garbukov EY; Menyailo ME; Khozyainova AA; Denisov EV; Cherdyntseva NV; Tashireva LA
Sci Rep; 2024 May; 14(1):12245. PubMed ID: 38806508
[TBL] [Abstract][Full Text] [Related]
25. Quantified postsurgical small cell size CTCs and EpCAM
Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
[TBL] [Abstract][Full Text] [Related]
26. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
Brown TC; Sankpal NV; Gillanders WE
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma.
Lee HJ; Kim GH; Park SJ; Kwon CH; Lee MW; Lee BE; Baek DH; I H
Gut Liver; 2021 Jul; 15(4):553-561. PubMed ID: 33293482
[TBL] [Abstract][Full Text] [Related]
28. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
29. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
[TBL] [Abstract][Full Text] [Related]
30. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
[TBL] [Abstract][Full Text] [Related]
32. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
33. Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.
Lampignano R; Schneck H; Neumann M; Fehm T; Neubauer H
Adv Exp Med Biol; 2017; 994():181-203. PubMed ID: 28560675
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
[TBL] [Abstract][Full Text] [Related]
35. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
36. Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
Woestemeier A; Ghadban T; Riethdorf S; Harms-Effenberger K; Konczalla L; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
Anticancer Res; 2018 Oct; 38(10):5665-5669. PubMed ID: 30275185
[TBL] [Abstract][Full Text] [Related]
37. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
38. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
[TBL] [Abstract][Full Text] [Related]
40. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.
Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D
Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
